| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Rituximab (Mabthera?) (Human) ELISA Kit |
|---|
| Description | Rituximab (Mabthera?) is a genetically engineered chimeric murine/human monoclonal antibody specific to CD20. CD20 is an approximately 35 KDa transmembrane phosphoprotein involved in the activation, proliferation, and differentiation of B-lymphocytes. It is absent in terminally differentiated plasma cells. The Fab domain of rituximab binds to the CD20 antigen on B-lymphocytes and the Fc domain recruits immune effector functions to induce apoptosis in B cells and is used in the treatment of leukemia s and lymphomas, some autoimmune disorders, and organ transplant. EMA Bio-analytical Method Validation Guidelines and industry-recommended practices for ligand-binding assays were used for validation of this kit. BioVision's Rituximab ELISA k |
|---|
| Size | 100 assays |
|---|
| Concentration | n/a |
|---|
| Applications | This ELISA kit is used for quantitative measurement of Rituximab in human serum and plasma |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | K4257-100 |
|---|
| Price | |
|---|
| Order / More Info | Rituximab (Mabthera®) (Human) ELISA Kit from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|